baber/WOPTO huggingface dataset:
Patent CS-257253-B2 (CS)
Title: Porous crystalic synthetic material on the base of silicon oxide and titanium dioxide and method of its production
Inventor: TARAMASSO MARCO
IPC: C01B39/12
Filed: 1980-12-12
Abstract: This invention relates to a porous crystalline synthetic material constituted by silicon and titanium oxides, a method for synthesizing said material, and the use thereof as a catalyst. Said material is given the name titanium silicalite or TS-1, and corresponds to the following formula: xTiO2.(1-x)SiO2 where x lies between 0.0005 and 0.04, preferably between 0.01 and 0.025. The material is prepared starting from a mixture constituted by a source of silicon oxide and a source of titanium oxide. The reaction takes place in the aqueous phase at a temperature of 130 DEG  to 200 DEG  C., and the solid product obtained is calcined in air at 550 DEG  C. The TS-1 can be used for alkylation of toluene with methanol, or benzene with ethylene or ethanol, disproportioning of toluene to produce paraxylol, for cracking, hydrocracking, isomerization of n-paraffins and naphthenes, reforming, isomerization of substituted polyalkyl aromatics, disproportioning of aromatics, conversion of dimethylether and/or methanol or other alcohols to hydrocarbons, polymerization of compounds containing olefine or acetylene bonds, conversion of aliphatic carbonyl compounds into at least partly aromatic hydrocarbons, separation of ethyl benzene from other C8 aromatic hydrocarbons, hydrogenation and dehydrogenation of hydrocarbons, methanation, oxidation, dehydration of aliphatic compounds containing oxygen, and conversion of olefines into compounds of high octane number.
Patent AU-684875-B2 (AU)
Title: Macrocyclic difluorostatone derivatives useful as antiviral agents
Inventor: FARR ROBERT A
IPC: A61P31/18
Filed: 1994-11-28
Granted: 1998-01-08
Abstract: PCT No. PCT/US94/13711 Sec. 371 Date Sep. 9, 1996 Sec. 102(e) Date Sep. 9, 1996 PCT Filed Nov. 28, 1994 PCT Pub. No. WO95/21186 PCT Pub. Date Aug. 10, 1995The present invention provides novel macrocyclic difluorostatone derivatives which are useful as antiviral agents. More specifically, these novel compounds are useful as inhibitors of retroviral proteases required for replication, particularly the HIV-1 and HIV-2 viral proteases, in the prevention or treatment of infection by the human immunodeficiency virus (HIV), and in the treatment of consequent pathological conditions such as the acquired immunodeficiency syndrome (AIDS) in mammals capable of being infected with HIV virus.
Patent AU-618952-B2 (AU)
Title: Expression of foreign genes in drosophila cells
Inventor: JOHANSEN HANNE RANCH
IPC: C12N9/48
Filed: 1988-05-03
Granted: 1992-01-16
Abstract: The present invention relates to the development of a selection system to co-introduce and express foreign genes in Drosophila cells particularly tissue plasminogen activator (tPA).
Patent AU-608336-B2 (AU)
Title: 2-(heterocyclylalkyl)imidazopyridines
Inventor: JANSSENS FRANS EDUARA
IPC: C07D473/00
Filed: 1988-07-08
Granted: 1991-03-28
Abstract: Antiallergic 2-(heterocyclylalkyl)imidazopyridines of formula <CHEM>  wherein -A<1>=A<2>-A<3>=A<4>- is -N=CH-CH=CH-, -CH=N-CH=CH-, -CH=CH-N=CH-, -CH=CH-CH=N-, -N=CH-N=CH- or -CH=N-CH=N-; R<1> is hydrogen, C1-10alkyl, C3-6cycloalkyl, Ar<1>, C1-6alkyl or a radical of formula -Alk-G-R<2>;  R is hydrogen or C1-6alkyl;  m is 1 to 4;  n is 1 or 2; L is hydrogen, C1-6alkylcarbonyl, C1-6alkylsulfonyl, C1-6alkyloxycarbonyl, Ar<2>-C1-6alkyloxycarbonyl, Ar<2>-carbonyl, Ar<2>-sulfonyl, C3-6cycloalkyl, C2-6alkenyl optionally substituted with Ar<2>, C1-12alkyl, a radical of formula -Alk-R<4>, -Alk-Y-R<5>, Alk-Z<1>-C(X)-Z<2>-R<6> or -CH2-CHOH-CH2-O-R<7>; the pharmaceutically acceptable acid addition salts and possible stereochemically isomeric forms thereof, novel compounds of formula (I); pharmaceutical compositions containing such compounds as an active ingredient and methods of preparing said compounds and pharmaceutical compositions.
Patent AU-713040-B2 (AU)
Title: Immunomodulatory oligonucleotides
Inventor: KRIEG ARTHUR M
IPC: C12Q1/68
Filed: 1995-02-07
Granted: 1999-11-18
Abstract: Stabilised immunostimulatory oligonucleotides which contain at least one unmethylated CpG dinucleotide for medicinal use.
Patent AU-698576-B2 (AU)
Title: Automated detection of lesions in computed tomography
Inventor: GIGER MARYELLEN L
IPC: A61B6/03
Filed: 1995-03-30
Granted: 1998-11-05
Abstract: A method and system for the automated detection of lesions in computed tomographic images, including generating image data from at least one selected portion of an object, for example, from CT images of the thorax. The image data are then analyzed in order to produce the boundary of the thorax. The image data within the thoracic boundary is then further analyzed to produce boundaries of the lung regions using predetermined criteria. Features within the lung regions are then extracted using multi-gray-level thresholding and correlation between resulting multi-level threshold images and between at least adjacent sections. Classification of the features as abnormal lesions or normal anatomic features is then performed using geometric features yielding a likelihood of being an abnormal lesion along with its location in either the 2-D image section or in the 3-D space of the object.
Patent AU-690692-B2 (AU)
Title: Catheter with deflectable distal section
Inventor: SCHAER ALAN K
IPC: A61M25/01
Filed: 1995-05-11
Granted: 1998-04-30
Abstract: An electrophysiology catheter assembly having a deflection mechanism rotatably disposed within an inner lumen of the catheter so that deflection of the deflection mechanism within the inner lumen results in a deflection of the distal portion of the catheter. Rotation of the deflection mechanism within the inner lumen of the catheter allows universal deflection of the distal portion of the catheter about its longitudinal axis. The deflection mechanism may be first rotated and then deflected or it may be first deflected and then rotated in a deflected condition. The catheter shaft does not need to be rotated to change the shape of its distal portion.
Patent AU-618042-B2 (AU)
Title: Polyvinyl alcohol derivatives containing pendant vinylic monomer reaction product units bound through ether groups and hydrogel contact lenses made therefrom
Inventor: GOLDENBERG MERRILL
IPC: G02B1/04
Filed: 1988-12-15
Granted: 1991-12-12
Abstract: A contact lens of a crosslinked, organic aprotic solvent insoluble, substantially transparent polymer of a derivative of a polyvinyl alcohol having a weight average molecular weight of at least about 2,000, containing an effective amount between about 0.1 and 90 percent, based on the number of hydroxyl groups on said polyvinyl alcohol, of a crosslinked addition reaction product of units of the formula   <CHEM> in the presence or absence of a polymerizable vinylic monomer wherein R<1> is a divalent aliphatic, cycloaliphatic, aryl, aralkyl or alkaryl group; A is -O-, -NH- or -NHCON(R sec )- where R sec  is hydrogen or lower alkyl and A min  is a direct bond; or A is a direct bond and A min  is -O- or -O-CH2-; R<2> is hydrogen or methyl; and R is hydrogen, methyl or -COOR<4> where R<4> is hydrogen or lower alkyl; with the proviso that if R<2> is methyl, R<3> is hydrogen; and wherein the polymerizable vinylic monomer, if present, is hydrophobic or is a mixture of hydrophobic and hydrophilic vinylic monomers in which mixture at least 50 % of vinyl monomers are hydrophobic.
Patent AU-691929-B2 (AU)
Title: Nucleic acid sequence encoding trypsin-like enzyme and process for producing the enzyme
Inventor: YAMAOKA KAZUYOSHI
IPC: C12N9/64
Filed: 1995-07-31
Granted: 1998-05-28
Abstract: This invention provides a nucleic acid sequence encoding a trypsin-like enzyme which can be present at the trachea of human lungs, and can selectively digest a synthetic substrate for trypsin and a synthetic substrate for thrombin, and fibrinogen; and a process for producing the trypsin-like enzyme by genetic engineering utilizing the nucleic acid sequence.
Patent AU-745237-B2 (AU)
Title: Automatic or semiautomatic wiping material and toilet paper dispensing apparatus
Inventor: GRANGER MAURICE
IPC: A47K10/36
Filed: 1999-03-22
Granted: 2002-03-14
Abstract: The invention concerns an apparatus characterized in that the drum (6) has on an angular sector (alpha) of its periphery a zone (17) with increased thickness capable of being in contact with the pressing means (11) substantially retractable in position through a float mounting to absorb the drum thickness modifications, in rotating phase when the material strip is pulled up to its cutting line.
Patent AU-757846-B2 (AU)
Title: Door lock, especially for motor vehicles
Inventor: SZABLEWSKI PIOTR
IPC: E05B65/32
Filed: 2000-02-17
Granted: 2003-03-06
Abstract: A rotary latch (11) of a door lock is retained in a detent position by a spring-mounted retainer (20). A motor-driven working member (47) is provided for lifting said retainer (20). An energy-storing device (30) subjects a storing member (22) to a force and hereby serves to lift the retainer (20) out of its detent position in the rotary latch (11). To this end, the storing member (22) has a control surface against which the working member (47) travels in a first motor phase in order to load the energy-storing device (30). A counter-control surface (29) against which the working member (47) travels when lifting the retainer (20) in a staggered second motor phase is also provided. The aim of the invention is to provide a reliable door lock which will also function in the event of an accident. To this end, both the control surface (23) and the counter-control surface (29) are located on the storing member (22). The additional force required for lifting the retainer (20) acts on said retainer indirectly through the storing member (22). As a result, the quantities of energy produced one after the other in the two motor drive phases can be transmitted spontaneously from the shoulder (32) of the storing member (22) to the counter-shoulder (33) of the retainer (20).
Patent AU-772635-B2 (AU)
Title: Pyrrolecarboxamides and pyrrolethioamides as fungicides
Inventor: WALTER HARALD
IPC: C07D207/40
Filed: 2001-01-19
Granted: 2004-05-06
Abstract: Novel pyrrole derivatives of formula I wherein X is oxygen or sulfur; R<SUB>1 </SUB>is C<SUB>1</SUB>-C<SUB>4</SUB>alkyl unsubstituted or substituted, with the exception of CF<SUB>3</SUB>; C<SUB>3</SUB>-C<SUB>6</SUB>cycloalkyl unsubstituted or substituted; or halogen; R<SUB>2 </SUB>is hydrogen, C<SUB>1</SUB>-C<SUB>4</SUB>alkyl unsubstituted or substituted, C<SUB>1</SUB>-C<SUB>4</SUB>alkoxy unsubstituted or substituted, cyano or halogen; R<SUB>3 </SUB>is C<SUB>1</SUB>-C<SUB>4</SUB>alkyl unsubstituted or substituted; and A is orthosubstituted aryl; orthosubstituted heteroaryl; bicycloaryl unsubstituted or substituted; or bicycloheteroaryl unsubstituted or substituted. The novel compounds have plant-protective properties and are suitable for protecting plants against infestations by phytopathogenic microorganisms.
Patent AU-667532-B2 (AU)
Title: Synthetic eukaryotic promoters containing two inducible elements
Inventor: FILMUS JORGE
IPC: C12P21/00
Filed: 1993-03-30
Granted: 1996-03-28
Abstract: PCT No. PCT/CA93/00130 Sec. 371 Date Oct. 20, 1994 Sec. 102(e) Date Oct. 20, 1994 PCT Filed Mar. 30, 1993 PCT Pub. No. WO93/20218 PCT Pub. Date Oct. 14, 1993Synthetic inducible eukaryotic promoters for the regulation of transcription of a gene achieve improved levels of protein expression and lower basal levels of gene expression. Such promoters contain at least two different classes of inducible elements, usually by modification of a native promoter containing one of the inducible elements by inserting the other of the inducible elements. In embodiments, additional metal responsive elements (MREs) and/or glucocorticoid responsive elements (GREs) are provided to native promoters, particularly the hMT-IIA and MMTV-LTR promoters. One or more constitutive elements may be functionally disabled to provide the lower basal levels of gene expression.
Patent AU-664614-B2 (AU)
Title: A convex ring
Inventor: OLSEN HANS
IPC: A61F5/448
Filed: 1993-03-19
Granted: 1995-11-23
Abstract: The invention concerns a convex ring for use in connection with an ostomy appliance consisting of at least two parts adapted to be coupled together, wherein a first coupling part (10, 110, 210, 310) is intended to be attached around the patient's stoma and comprises a ring-shaped part protruding in a distal direction, said ring (1, 101, 201, 301) being of a relatively rigid material and having a radial extent between the inner periphery (2, 102, 202, 302) of an inner wall section and the outer periphery (4, 104, 204, 304) of an outer wall section, and a proximal side (6, 106, 206, 306) and a distal side (7, 107, 207, 307), at least the proximal side of said inner wall section having a convex surface, said outer wall section (5b, 105b, 205b, 305b) having at its outer periphery an edge or a flange (4a, 104a, 204a, 304a) that can be caused to engage an edge or a flange or a plurality of knobs (18, 118, 218, 318) on a radially inner side (17, 117, 217, 317) of the ring-shaped part of the first coupling part, said ring (1, 101, 201, 301) having on the outer wall section (5b, 105b, 205b, 305b) a part (8, 108, 208, 308) protruding in a distal direction.
Patent AU-674513-B2 (AU)
Title: Peptide derivatives corresponding to the carboxy terminal sequence of hirudin
Inventor: BRUNDISH DEREK EDWARD
IPC: C07D211/62
Filed: 1993-04-15
Granted: 1997-01-02
Abstract: PCT No. PCT/EP93/00908 Sec. 371 Date Oct. 20, 1994 Sec. 102(e) Date Oct. 20, 1994 PCT Filed Apr. 15, 1993 PCT Pub. No. WO93/22344 PCT Pub. Date Nov. 11, 1993Novel compounds of the formula I    <IMAGE>l or are linked to form C3-C7 cycloalkyl and R3, R4 and R5 are the same or different and are hydrogen, C1-C4 alkyl, hydroxy, OR6, SR6, halogen, NR7R8, NO2, CN, CONR7R8 or CO2R9 wherein R6 is C1-C4 alkyl or C7-C10 aralkyl and R7, R8 and R9 are the same or different and are hydrogen, C1-C4 alkyl or C7-C10 aralkyl or R7 and R8 together with the nitrogen atom to which they are bound form 5 or 6 membered azacycloalkyl or oxazacycloalkyl; Arg is arginine [NH-CH(CH2CH2CH2NH-C(=NH)-NH2)-CO]; X is methine CH or nitrogen; n is an integer from 0 to 7; L is a peptide linker, and H is the carboxy terminal end of hirudin, and salts thereof, are provided. The novel compounds are useful for the medical treatment or prevention of thrombosis or diseases caused by thrombosis or can be used for the determination of thrombin in blood as diagnostic reagents.
Patent AU-778348-B2 (AU)
Title: Fastener for a modular implant
Inventor: RENZ RICHARD L
IPC: A61F2/46
Filed: 2000-06-15
Granted: 2004-12-02
Abstract: A joint between an implant body component and a stem component provides an initially rigid connection that further remains rigid even if the joint settles upon being loaded. The body and stem have portions comprising a male/female taper junction. A fastener maintains the taper junction in tight engagement. The fastener engages the implant components and draws them together. The fastener includes a resilient portion that deflects such that if settling occurs, the resilient portion maintains compressive contact between the fastener and the components.
Patent AU-663787-B2 (AU)
Title: Cosmetic sunscreen
Inventor: FINKEL PETER
IPC: A61K8/37
Filed: 1993-06-30
Granted: 1995-10-19
Abstract: The present invention relates to a cosmetic sunscreen in emulsion form for external use based on absorbing and reflecting substances in combination with a radical scavenger system, and to a process for producing it.
Patent AU-770470-B2 (AU)
Title: Card shuffling device
Inventor: BLAHA ERNST
IPC: A63F1/12
Filed: 2001-03-26
Granted: 2004-02-19
Abstract: A card shuffler is disclosed having a card output portion that is easily connectable to either a first output card receiver or a second output card receiver. The first output card receiver enables the dealer to remove cards one at a time from the shuffler. The second output card receiver enables the dealer to remove a group of cards at a time from the shuffler.
Patent AU-727735-B2 (AU)
Title: Use of a melanoma differentiation associated gene (mda 7) for reversing cancerous phenotype
Inventor: FISHER PAUL B
IPC: A61P35/00
Filed: 1997-08-15
Granted: 2000-12-21
Abstract: This invention provides a method for reversing the cancerous phenotype of a cancer cell by introducing a nucleic acid having the melanoma differentiation associated gene ( mda-7 ) into the cell under conditions that permit the expression of the gene so as to thereby reverse the cancerous phenotype of the cell. This invention also provides a method for reversing the cancerous phenotype of a cancer cell by introducing the gene product of the above-described gene into the cancerous cell so as to thereby reverse the cancerous phenotype of the cell. This invention also provides a pharmaceutical composition having an amount of a nucleic acid having the melanoma differentiation associated gene ( mda-7 ) or the gene product of a melanoma differentiation associated gene ( mda-7 ) effective to reverse the cancerous phenotype of a cancer cell and a pharmaceutically acceptable carrier.
Patent AU-667113-B2 (AU)
Title: Non-invasive method and means for (in-vivo) bone-growth stimulation
Inventor: MCLEOD KENNETH J
IPC: A61H1/02
Filed: 1993-05-26
Granted: 1996-03-07
Abstract: A method and apparatus for preventing osteopenia, promoting bone tissue growth, ingrowth, and healing of bone tissue includes the step of and means for applying a mechanical load to the bone tissue at a relatively low level on the order of between about 50 and about 500 microstrain, peak-to-peak, and at a relatively high frequency in the range from about 10 and about 100 Hz. Mechanical loading at such strain levels and such frequencies has been found to prevent bone loss and enhance new bone formation.
Patent AU-700527-B2 (AU)
Title: Electronic television program guide schedule system and method with display and search of program with alphabetical title listings
Inventor: YOUMAN ROGER
IPC: H04N5/50
Filed: 1995-11-28
Granted: 1999-01-07
Abstract: An electronic program schedule system which includes a receiver for receiving broadcast, satellite or cablecast television programs for a plurality of television channels and a tuner for tuning a television receiver to a selected one of the plurality of channels. A data processor receives and stores in a memory television program schedule information for a plurality of television programs to appear on the plurality of television channels. A user control apparatus, such as a remote controller, is utilized by a viewer to choose user control commands and transmit signals in response to the data processor which receives the signals in response to user control commands. A television receiver is used to display the television programs and television program schedule information. A video display generator receives video control commands from the data processor and program schedule information from the memory and displays a portion of the program schedule information in overlaying relationship with a television program appearing on a television channel in at least one mode of operation of the television programming guide. The data processor controls the video display generator with video control commands, issued in response to the user control commands, to display program schedule information for any chosen one of the plurality of television programs in overlaying relationship with at least one television program then appearing on any chosen one of the plurality of channels on the television receiver. <IMAGE>
Patent AU-689024-B2 (AU)
Title: Esters and amides of non-steroidal anti-inflammatory carboxylic acids which may be used as anti-oxidants, 5-lipoxygenase inhibitors and non-steroidal anti-inflammatory products
Inventor: HELLBERG MARK
IPC: C07C235/34
Filed: 1995-12-21
Granted: 1998-03-19
Abstract: Methods for treating vascular inflammatory pathologies are disclosed. Particularly, the methods utilize pharmaceutical compositions containing certain compounds having an anti-inflammatory and anti-oxidant moiety covalently linked by an amide or ester bond. The compounds are useful in preventing and treating inflammatory disorders through several mechanisms.
Patent AU-524494-B2 (AU)
Title: Quantitive determination of a serum protein in turbid serum and plasma samples
Inventor: HEUCK CLAUS-CHRISTIAN
IPC: G01N33/92
Filed: 1979-07-04
Granted: 1982-09-16
Abstract: The invention relates to a process for the quantitative determination of a serum protein, especially apolipoprotein, in turbid serum or plasma samples by nephelometry, which comprises, after having carried out an immunologic reaction with the corresponding antibody, measuring in the presence of a tenside of the formula CH3-(CH2)m-R-(CH2-CH2-O)n-H (I) in which R is O; NH; CHCH(CH2)xNH; +TR  <IMAGE>   Y is H- or CH3-(CH2)q-, m and q, being identical or different; each are an integer of from 6 to 26, preferably 6 to 18; n is an integer of from 7 to 50, preferably 7 to 25; and x is 7 or 8; the tenside being used in a concentration of from 10-3 to 10-1% by volume. Alternatively, the measures can be taken after enzymatic degradation of the lipids and subsequent immunologic reaction with the corresponding antibody in the presence of a nonionic tenside of the formula (I), in which R is as defined above, or   <IMAGE> +TR R' being CH3 or C2H5,  Further subjects of the invention are the use of a tenside of the cited formula for serum work-up for quantitative determination of an apolipoprotein, and an agent for serum work-up for quantitative determination for an apolipoprotein, consisting of a mixture of at least one lipid-degrading enzyme and a tenside of the cited formula.
Patent AU-768062-B2 (AU)
Title: An apparatus and a method for increasing the power of an internal combustion engine operated using an exhaust gas turbocharger
Inventor: SCHLOGL HARALD
IPC: F02B39/10
Filed: 2000-07-21
Granted: 2003-12-04
Abstract: The arrangement has a compressor (15) in addition to the exhaust gas turbocharger (2) with its compressor wheel connected to the shaft of a high speed electric motor (16). The motor can perform extreme speed changes in fractions of a second, if required high revolution rates and has a maximum output power of about 5 to 30 kW and receives the required electrical drive energy from a machine (17) operated as a generator, which is connected to the engine's crankshaft and controlled by a regulator, and/or a battery. The additional compressor can supply additional air to increase the power. An Independent claim is also included for a method of increasing the power of an internal combustion engine with an exhaust gas turbocharger.
Patent AU-573046-B2 (AU)
Title: Dust flow inducing monitor
Inventor: NEWTON ROBERT
IPC: G01N27/04
Filed: 1985-10-07
Granted: 1988-05-26
Abstract: Airborne dust concentration in a silo or the like is measured by inducing flow in one or more Venturi nozzles (10) located in the area of airborne dust. A triboelectric sensor probe electrode (20) is located at the nozzle inlet section (12) and flow is induced by a feed of inductive air through an annular channel located in the wall of the nozzle downstream of the electrode.
Patent AU-707331-B2 (AU)
Title: Machining of materials
Inventor: O'NEILL W
IPC: B23K26/14
Filed: 1996-04-10
Granted: 1999-07-08
Abstract: A method of machining a blind slot 3 in a workpiece 2 comprises heating the surface of the workpiece 2 above its melting temperature with, for example, a beam of laser energy and directing at least two gas streams 5. 6 such that they together with the base of the slot 3, create a vortex having a predetermined rotational direction for removing molten material from the slot 3. <IMAGE>